Journals / Black Sea Journal of Health Science / 2022 / Cilt: 5 - Sayı: 2

Molecules That Show Immunomodulator Effect on Natural Killer Cell Activity

Doğal Öldürücü Hücre Aktivitesinde İmmunomodulatör Etki Gösteren Moleküller

Pages
312–317
Publication Date
2022-05-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, the mechanisms of action of NK cells and molecules that have immunomodulatory effects on NK cell activity are discussed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Natural Killer (NK) cells are responsible for defending against viral infections and eliminating malignant cells.
📊
Key Findings & Data:Cancer immunotherapy strategies aim to benefit from the ability of T cells, NK cells, NK-T cells, B cells, dendritic cells and macrophages to recognize and eliminate cancer cells.
💡
Conclusion & Impact:In this review, the mechanisms of action of NK cells and molecules that have immunomodulatory effects on NK cell activity are discussed.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Anti-tümör · İmmünoterapi · NK hücreleri

Abstract

Natural Killer (NK) cells are responsible for defending against viral infections and eliminating malignant cells. NK activity is regulated by surface receptors with activating and inhibitory effects, the action of cytokines, and their interactions with other immune cells. Cancer immunotherapy strategies aim to benefit from the ability of T cells, NK cells, NK-T cells, B cells, dendritic cells and macrophages to recognize and eliminate cancer cells. Natural killer cell receptors are responsible for regulating NK cell activation and homeostasis. The balance between activating and inhibitory signals transmitted from these receptors controls NK cell functionality. Activator receptors include cytotoxicity receptors (NCRs) (NKp46, NKp30 and NKp44) and CD94/NKG2C, NKG2D, NKG2E/H and NKG2F receptors. Inhibitory receptors include C-type lectin receptors (CD94 / NKG2A / B) and KIR receptors (KIR-2DL and KIR-3DL). In this review, the mechanisms of action of NK cells and molecules that have immunomodulatory effects on NK cell activity are discussed.

Özet

Doğal Öldürücü (NK) hücreleri viral enfeksiyonlara karşı savunmadan ve malignant hücrelerin elimine edilmesinden sorumludur. NK aktivitesi, aktivatör ve inhibitör etkiye sahip yüzey reseptörleri, sitokinlerin etkisi ve diğer immun hücrelerle yaptıkları etkileşimler tarafından düzenlenir. Kanser immünoterapi stratejilerinde, T hücreleri, NK hücreler, NK-T hücreleri, B hücreleri, dendritik hücreler ve makrofajların kanser hücrelerini tanıma ve elimine etme özelliklerinden yararlanılması amaçlanır. Doğal öldürücü hücre reseptörleri, NK hücresi aktivasyonunu ve homeostazını düzenlemeden sorumludurlar. Bu reseptörlerden iletilen aktive edici ve inhibitör sinyaller arasındaki denge NK hücre işlevselliğini kontrol eder. Aktivatör reseptörler, sitotoksisite reseptörlerini (NCRs) (NKp46, NKp30 ve NKp44) ve CD94/NKG2C, NKG2D, NKG2E/H ve NKG2F reseptörlerini içerir. İnhibitör reseptörler arasında C-tipi lektin reseptörleri (CD94 / NKG2A / B) ve KIR reseptörleri (KIR-2DL ve KIR-3DL) bulunur. Derlemede NK hücrelerinin etki mekanizmaları ve NK hücre aktivitesine immunomodülatör etki gösteren moleküller ele alınmıştır .

🔖

Cite This Article

KAYA, H., GÜLTEKİN, S. K., ARSLAN, B. A. (2022). Molecules That Show Immunomodulator Effect on Natural Killer Cell Activity. Black Sea Journal of Health Science, Cilt: 5 - Sayı: 2, 312–317. https://ajindex.com/articles/745235

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Abel AM, Yang C, Thakar MS, Malarkannan S. 2018. Natural killer cells: Development, maturation and clinical utilization. Front Immunol, 9: 1869. Arslan BA, Timucin AC. 2020. Immunotherapy approaches on innate immunity for SARS-Cov-2. Acta Virol, 64(4): 389-395.
  2. Atasever B, Ertan NZ, Erdem-Kuruca S, Karakas Z. 2006. In vitro effects of vitamin c and selenium on nk activity of patients with β-Thalassemia major. Pediat Hematol Oncol, 23: 187–197.
  3. Atasever Arslan B, Erdem-Kuruca S, Karakas Z, Erman B, Ergen A. 2013. Effects of micro environmental factors on natural killer activity (NK) of Beta Thalassemia major patients. Cellular Immunol, 282: 93-99.
  4. Bekaroğlu MG, Arslan BA. 2014. Natural killer (NK) cells in β Thalassemia major patients. JSM Biotechnol Bioeng, 2(2): 1040. Berrien-Elliott MM, Romee R, Fehniger TA. 2015. Improving natural killer cell cancer immunotherapy. Curr Opin Organ Transplant, 20(6): 671-680.
  5. Bi J, Tian Z. 2019. NK cell dysfunction and checkpoint immunotherapy. Front Immunol, 10: 1999.
  6. Bowen KE, Mathew SO, Borgmann K, Ghorpade A, Mathew PA. 2018. A novel ligand on astrocytes interacts with natural cytotoxicity receptor NKp44 regulating immune response mediated by NK cells. PloS One, 13(2): e0193008. Castriconi R, Cantoni C, Chiesa MD, Vitale M, Marcenaro E, Conte R, Biassoni R, Bottino C, Moretta L, Moretta A. 2003. Transforming growth factor β1 inhibits expression of NKp30 and NKG2D receptors: Consequences for the NK-mediated killing of dendritic cells. Proc Natl Acad Sci USA, 100(7): 4120-4125.
  7. Cichocki F, Miller JS. 2019. Setting traps for NKG2A gives NK cell immunotherapy a fighting chance. J Clin Invest, 129(5): 1839-1841.
  8. Cheng M, Chen Y, Xiao W, Sun R, Tian Z. 2013. NK cell-based immunotherapy for malignant diseases. Cell Mol Immunol, 10(3): 230-252.
  9. Cifaldi L, Doria M, Cotugno N, Zicari S, Cancrini C, Palma P, Rossi P. 2019. DNAM-1 Activating Receptor and Its Ligands: How Do Viruses Affect the NK Cell-Mediated Immune Surveillance during the Various Phases of Infection ?. Int J Mol Sci, 20(15): 3715. Frutoso M, Mortier E. 2019. NK cell hyporesponsiveness: More ıs not always better. Int J Mol Sci, 20(18): 4514. Grudzien M, Rapak A. 2018. Effect of natural compounds on NK cell activation. J Immunol Res, 2018: 4868417. Gwalani LA, Orange JS. 2018. Single degranulations in NK cells can mediate target cell killing. J Immunol, 200(9): 3231-3243.
  10. Khan M, Arooj S, Wang H. 2020. NK cell-based immune checkpoint inhibition. Front Immunol, 11: